Lenalidomide enhances the function of dendritic cells generated from patients with multiple myeloma
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2016-11-23 / Exp. Hematol. 2017 Feb;46:48-55Efficacy of host-dendritic cell vaccinations with or without minor histocompatibility antigen loading, combined with donor lymphocyte infusion in multiple myeloma patients
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2016-11-14 / Bone Marrow Transplant. 2017 Feb;52(2):228-237Novel vaccines for glioblastoma: clinical update and perspective
/in Dendritic Cells, Glioblastoma, International Publications /von 2016-11-01 / Immunotherapy 2016 11;8(11):1293-1308Dendritic Cells and Cancer Immunity
/in Dendritic Cells, International Publications /von 2016-10-25 / Trends Immunol. 2016 12;37(12):855-865Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cells
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2016-10-18 / Oncoimmunology 2016;5(11):e1232237Immunotherapy in pancreatic cancer treatment: a new frontier
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2016-10-17 / Therap Adv Gastroenterol 2017 Jan;10(1):168-194Phase I/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastoma
/in Dendritic Cells, Glioblastoma, International Publications /von 2016-09-29 / Cancer Immunol. Immunother. 2016 12;65(12):1499-1509Induction of Immune Response after Allogeneic Wilms‘ Tumor 1 Dendritic Cell Vaccination and Donor Lymphocyte Infusion in Patients with Hematologic Malignancies and Post-Transplantation Relapse
/in Acute Leukemia, Dendritic Cells, International Publications /von 2016-09-12 / Biol. Blood Marrow Transplant. 2016 12;22(12):2149-2154A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2016-08-24 / J. Biomed. Sci. 2016 Aug;23(1):64
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de